+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan



Kinetic constants of leukocyte reduction in the course of treatment of chronic myeloleukosis with different doses of myelosan



Izvestiia Akademii Nauk Sssr. Seriia Biologicheskaia 5: 739-743




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 043498071

Download citation: RISBibTeXText

PMID: 5262634


Related references

Kinetic constants of leukocyte reduction in the course of treatment of neopl chronic myelo leukosis with different doses of myelosan anti neoplastic human. Izvestiya Akademii Nauk SSSR Seriya Biologicheskaya (5): 739-743, 1968

Treatment of chronic myeloleukosis with myelosan. Klinicheskaia Meditsina 36(7): 82-88, 1958

Method of treatment of chronic myeloleukosis with myelosan. Klinicheskaia Meditsina 36(7): 89-93, 1958

On the tactics of myelosan therapy of chronic myeloleukosis. Terapevticheskii Arkhiv 39(2): 3-9, 1967

Myelosan (1,4-dimethanesulfoniloxybutane) and its significance in the therapy of chronic myeloleukosis. Klinicheskaia Meditsina 36(7): 73-82, 1958

The development of aplasia of hematopoiesis after the use of myelosan in patients with chronic myeloleukosis. Sovetskaia Meditsina 30(12): 67-71, 1967

Kinetic criteria of the effectiveness of treatment of chronic myeloleukosis. Izvestiia Akademii Nauk Sssr. Seriia Biologicheskaia 4: 566-572, 1973

Use of the kinetic method for evaluation of the effectiveness of treating chronic leukemia patients with myelosan and degranol and their effect on the hemogram. Problemy Gematologii i Perelivaniia Krovi 16(5): 14-16, 1971

The calculation of kinetic constants for the anthranilate synthetase catalyzed formation of anthranilic acid part 1 possible reaction mechanisms and determination of kinetic constants from the steady state kinetic data. Bioorganicheskaya Khimiya 1(10): 1505-1514, 1975

Result of use of dopan in treatment of chronic myeloleukosis. Sovetskaia Meditsina 22(9): 42-46, 1958

Myelobromol treatment of patients with chronic myeloleukosis. Klinicheskaia Meditsina 45(7): 96-104, 1967

Myeloblastic Attacks in Chronic Myeloleukosis and their Treatment. Terapevticheskii Arkhiv 35: 97-101, 1963

Clinical experience with Myelobromol in the treatment of chronic myeloleukosis. Haematologia 1(1): 61-77, 1967

The use of dopan and myelosan in the treatment of chronic myeloleukemia. Sovet Med 26(5): 30-33, 1963

Chronic myelosis treatment with Myleran (Myelosan). Folia Medica 20(1): 54-58, 1978